Neoadjuvant Immunotherapy for T4 dMMR Colon Cancer

Conditions: Colon Cancer; Mismatch Repair Deficiency; Immunotherapy Interventions: Drug: Camrelizumab Sponsors: Peking Union Medical College Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials